Additionally, Cmero et al. showed that Snai2 expression is upregulated in patients receiving acute ADT [71], and moreover, upregulation of Snai2 is associated with poor prognosis in a number of cancer contexts [87,88,89,90]. The gene discussed is SNAI2; the disease is cancer.